Open Label, Randomised Multicentre Phase III Study Of Irinotecan Hydrochloride (Campto (Registered)) And Cisplatin Versus Etoposide And Cisplatin In Chemotherapy Naive Patients With Extensive Disease - Small Cell Lung Cancer
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006662/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To compare the effects of irinotecan hydrochloride with cisplatin to the "standard" regimen
etoposide plus cisplatin on overall survival, in chemotherapy-naive patients with newly
diagnosed Extensive Disease-Small Cell Lung Cancer (ED-SCLC).
提供机构：
Vivli
创建时间：
2021-02-09
